Adam M Veness
CIK 1778623 · SVP, General Counsel and Sec. · last filed 2026-08-14
Adam M Veness is a SVP, General Counsel and Sec. who has filed 27 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing shows the insider exercised options covering $272.6K of DNTH on Aug 14, 2026. Across all open-market trades the lifetime net is −$7.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.60M
3
27
-$7.03M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DNTH | SVP, General Counsel and Sec. | 15,000 | $106.62 | $1.60M | -$4.63M | 7 | 2026-08-14 |
| Cyteir Therapeutics, Inc. (CYT) Delisted | General Counsel | — | $3.02 | — | $0 | 2 | 2023-02-07 |
| ACCELERON PHARMA INC (XLRN) Delisted | SVP, General Counsel and Sec. | 0 | $178.75 | $0 | -$2.40M | 15 | 2021-11-22 |
Recent Filings
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-14 | DNTH | Exer (M) | +15,000 | $272.6K | EDGAR |
| 2026-08-11 | DNTH | Mixed | — | -$1.85M | EDGAR |
| 2026-08-10 | DNTH | Notice (144) | −16,167 | -$1.76M | EDGAR |
| 2026-08-07 | DNTH | Notice (144) | −3,833 | -$421.3K | EDGAR |
| 2026-06-18 | DNTH | Mixed | — | -$1.89M | EDGAR |
| 2026-06-17 | DNTH | Notice (144) | −30,000 | -$2.37M | EDGAR |
| 2026-02-04 | DNTH | Grant (A) | — | $0 | EDGAR |
| 2025-02-04 | DNTH | Grant (A) | — | $0 | EDGAR |
| 2024-05-28 | DNTH | Grant (A) | — | $0 | EDGAR |
| 2024-01-26 | DNTH | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.